Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$733,530
+$688,293 QoQ
Shares Held
2,915
+1301.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#2,849
of 4,167 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SWISS RE LTD holds $5,737,531 across 8 Drug Manufacturers - General names. ABBV ranks #4 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,655 | $1,985,056 | |
| 2 | JNJ |
Johnson & Johnson
|
5,719 | $1,452,454 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,058 | $778,453 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,915 | $733,530 | |
| 5 | AMGN |
Amgen Inc
|
784 | $283,902 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,083 | $263,166 | |
| 7 | PFE |
Pfizer Inc
|
5,152 | $124,060 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,029 | $116,910 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $733,530 | 2,915 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $45,237 | 208 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $47,525 | 208 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||